Cargando…

Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry

BACKGROUND: Data on the use of the wearable cardioverter‐defibrillator (WCD) among patients with myocarditis remain sparse. Consequently, evidence for guideline recommendations in this patient population is lacking. METHODS AND RESULTS: In total, 1596 consecutive patients were included in a multicen...

Descripción completa

Detalles Bibliográficos
Autores principales:	El‐Battrawy, Ibrahim, Koepsel, Katharina, Tenbrink, David, Kovacs, Boldizsar, Dreher, Tobias C., Blockhaus, Christian, Gotzmann, Michael, Klein, Norbert, Kuntz, Thomas, Shin, Dong‐In, Lapp, Hendrik, Rosenkaimer, Stephanie, Abumayyaleh, Mohammad, Hamdani, Nazha, Saguner, Ardan Muammer, Kowitz, Jacqueline, Erath, Julia W., Duru, Firat, Mügge, Andreas, Akin, Ibrahim, Aweimer, Assem, Beiert, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547297/ https://www.ncbi.nlm.nih.gov/pubmed/37681569 http://dx.doi.org/10.1161/JAHA.123.030615

Ejemplares similares

Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
por: El-Battrawy, Ibrahim, et al.
Publicado: (2022)

Incidence, recurrence and management of electrical storm in Brugada syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2022)

Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy
por: Abumayyaleh, Mohammad, et al.
Publicado: (2021)

The impact of sacubitril/valsartan on outcome in patients suffering from heart failure with a concomitant diabetes mellitus
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2022)

Pooled Analysis of Complications with Transvenous ICD Compared to Subcutaneous ICD in Patients with Catecholaminergic Polymorphic Ventricular Arrhythmia
por: Eckert, Henrik, et al.
Publicado: (2022)

In-hospital triggers of takotsubo syndrome: a case report on witnessing sudden death in a hospital roommate
por: Aweimer, Assem, et al.
Publicado: (2023)

Hemodynamic Effects of Sacubitril/Valsartan in Patients with Reduced Left Ventricular Ejection Fraction Over 24 Months: A Retrospective Study
por: Abumayyaleh, Mohammad, et al.
Publicado: (2022)

A Case Series of Concomitant Cardiac Electrical Disease among Takotsubo Syndrome Patients and Literature Review
por: El-Battrawy, Ibrahim, et al.
Publicado: (2022)

Arrhythmogenic Cardiomyopathy: from Preclinical Models to Genotype–phenotype Correlation and Pathophysiology
por: Fan, Xuehui, et al.
Publicado: (2023)

Impact of P‐wave indices in prediction of atrial fibrillation—Insight from loop recorder analysis
por: Kreimer, Fabienne, et al.
Publicado: (2021)

Kidney Failure among Patients with Takotsubo Syndrome or Myocardial Infarction: A Retrospective Analysis
por: Bill, Verena, et al.
Publicado: (2022)

Abnormal Cardiac Repolarization in Thyroid Diseases: Results of an Observational Study
por: Aweimer, Assem, et al.
Publicado: (2021)

The link between ischaemic stroke, ischaemic heart disease, and atrial fibrillation
por: El-Battrawy, Ibrahim, et al.
Publicado: (2023)

Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)

Impact of Chronobiological Variation in Takotsubo Syndrome: Prognosis and Outcome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2021)

Variable Brugada syndrome phenotype severity in a dish: dreams meet reality
por: El-Battrawy, Ibrahim, et al.
Publicado: (2023)

Angiotensin Converting Enzyme Inhibitors versus Receptor Blockers in Patients with Ventricular Tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)

The Wearable Cardioverter-Defibrillator: Experience in 153 Patients and a Long-Term Follow-Up
por: Rosenkaimer, Stephanie L., et al.
Publicado: (2020)

Dose escalation for stereotactic arrhythmia radioablation of recurrent ventricular tachyarrhythmia - a phase II clinical trial
por: Kovacs, Boldizsar, et al.
Publicado: (2023)

Prognostic Value of Cardiac Troponin I in Patients with Ventricular Tachyarrhythmias
por: Akin, Ibrahim, et al.
Publicado: (2022)

Stress-Mediated Abnormalities in Regional Myocardial Wall Motion in Young Women with a History of Psychological Trauma
por: Aweimer, Assem, et al.
Publicado: (2023)

Prognostic value of beta-blocker doses in patients with ventricular tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)

Oxidative stress and inflammation distinctly drive molecular mechanisms of diastolic dysfunction and remodeling in female and male heart failure with preserved ejection fraction rats
por: Zhazykbayeva, Saltanat, et al.
Publicado: (2023)

Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screening
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2021)

Takotsubo Syndrome: Translational Implications and Pathomechanisms
por: Fan, Xuehui, et al.
Publicado: (2022)

Cardiomyocyte Dysfunction in Inherited Cardiomyopathies
por: Hassoun, Roua, et al.
Publicado: (2021)

Statin therapy is associated with improved survival in patients with ventricular tachyarrhythmias
por: Rusnak, Jonas, et al.
Publicado: (2019)

Cardiac disease and prognosis associated with ventricular tachyarrhythmias in young adults and adults
por: Weidner, Kathrin, et al.
Publicado: (2022)

Impact of age on the prognosis of patients with ventricular tachyarrhythmias and aborted cardiac arrest
por: Weidner, Kathrin, et al.
Publicado: (2022)

Atrial Fibrillation Is Associated with Increased Mortality in Patients Presenting with Ventricular Tachyarrhythmias
por: Behnes, Michael, et al.
Publicado: (2019)

Type 2 diabetes is independently associated with all-cause mortality secondary to ventricular tachyarrhythmias
por: Weidner, Kathrin, et al.
Publicado: (2018)

The molecular mechanisms associated with the physiological responses to inflammation and oxidative stress in cardiovascular diseases
por: Zhazykbayeva, Saltanat, et al.
Publicado: (2020)

Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction
por: Budde, Heidi, et al.
Publicado: (2022)

Hemodynamic Changes in the Right Ventricle Induced by Variations of Cardiac Output: A Possible Mechanism for Arrhythmia Occurrence in the Outflow Tract
por: Gülan, Utku, et al.
Publicado: (2019)

Prognostic Impact of Acute Myocardial Infarction in Patients Presenting With Ventricular Tachyarrhythmias and Aborted Cardiac Arrest
por: Behnes, Michael, et al.
Publicado: (2018)

Electrical storm reveals worse prognosis compared to myocardial infarction complicated by ventricular tachyarrhythmias in ICD recipients
por: Müller, Julian, et al.
Publicado: (2021)

Long-Term Performance Comparison of Bipolar Active vs. Quadripolar Passive Fixation Leads in Cardiac Resynchronisation Therapy
por: Schiedat, Fabian, et al.
Publicado: (2021)

The Link Between Sex Hormones and Susceptibility to Cardiac Arrhythmias: From Molecular Basis to Clinical Implications
por: Costa, Sarah, et al.
Publicado: (2021)

Brugada Syndrome Associated with Different Heterozygous SCN5A Variants in Two Unrelated Families
por: Molitor, Nadine, et al.
Publicado: (2022)

Publisher Correction: Mortality rates of severe COVID-19-related respiratory failure with and without extracorporeal membrane oxygenation in the Middle Ruhr Region of Germany
por: Aweimer, Assem, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t1m5i0n55ppfb3ct73b0c88egg